Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, China.
National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, 310052, China.
World J Pediatr. 2020 Jun;16(3):247-250. doi: 10.1007/s12519-020-00347-3. Epub 2020 Feb 28.
The outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV) has become a most challenging health emergency. Owing to rigorous quarantine and control measures taken in China, routine neonatal health surveillance and follow-up have become challenging. Without follow-up surveillance, some rapid and progressive newborn diseases, such as bilirubin encephalopathy, may be ignored. The characteristics of onset age of kernicterus suggest that monitoring of bilirubin level at home provides a useful way to alert hospital visits and to prevent the development of extremely hyperbilirubinemia. Therefore, we developed an online follow-up program for convenient monitoring of bilirubin level of newborns that is based on our practical experiences. The aim is to make our management strategies of neonatal jaundice tailored to the infection prevention and control during the COVID-19 epidemic.
2019 冠状病毒病（COVID-19；正式名称为 2019-nCoV）的爆发已成为最具挑战性的卫生紧急事件。由于中国采取了严格的检疫和控制措施，常规的新生儿健康监测和随访变得具有挑战性。如果没有随访监测，一些快速和进行性的新生儿疾病，如胆红素脑病，可能会被忽视。核黄疸发病年龄的特点表明，在家中监测胆红素水平为医院就诊提供了一种有用的预警方式，可防止发生极高胆红素血症。因此，我们根据实际经验，开发了一个在线随访程序，以方便监测新生儿的胆红素水平。目的是使我们的新生儿黄疸管理策略适应 COVID-19 流行期间的感染防控。
